1 Introduction to Research & Analysis Reports
1.1 Minimally Invasive Treatment of Lung Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Minimally Invasive Treatment of Lung Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Minimally Invasive Treatment of Lung Cancer Overall Market Size
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2029
2.2 Global Minimally Invasive Treatment of Lung Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.2 Top Global Minimally Invasive Treatment of Lung Cancer Companies Ranked by Revenue
3.3 Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies
3.4 Top 3 and Top 5 Minimally Invasive Treatment of Lung Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.6.1 List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Minimally Invasive Treatment of Lung Cancer Market Size Markets, 2022 & 2029
4.1.2 Lung Tumor Ablation
4.1.3 Lung Tumor Embolization
4.2 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
4.2.1 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
4.2.2 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
4.2.3 By Type – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.2 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
5.2.1 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
5.2.2 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
5.2.3 By Application – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2029
6.2 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
6.2.1 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
6.2.2 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue, 2024-2029
6.2.3 By Region – Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.3.2 US Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.3 Canada Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.3.4 Mexico Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.4.2 Germany Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.3 France Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.4 U.K. Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.5 Italy Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.6 Russia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.4.8 Benelux Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.5.2 China Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.3 Japan Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.4 South Korea Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.5.6 India Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.6.2 Brazil Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.6.3 Argentina Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2029
6.7.2 Turkey Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.3 Israel Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
6.7.5 UAE Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2029
7 Minimally Invasive Treatment of Lung Cancer Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Olympus
7.2.1 Olympus Company Summary
7.2.2 Olympus Business Overview
7.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.2.4 Olympus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.2.5 Olympus Key News & Latest Developments
7.3 LungCare
7.3.1 LungCare Company Summary
7.3.2 LungCare Business Overview
7.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.3.4 LungCare Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.3.5 LungCare Key News & Latest Developments
7.4 Broncus
7.4.1 Broncus Company Summary
7.4.2 Broncus Business Overview
7.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.4.4 Broncus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.4.5 Broncus Key News & Latest Developments
7.5 Intuitive Surgica
7.5.1 Intuitive Surgica Company Summary
7.5.2 Intuitive Surgica Business Overview
7.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.5.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.5.5 Intuitive Surgica Key News & Latest Developments
7.6 Auris Health
7.6.1 Auris Health Company Summary
7.6.2 Auris Health Business Overview
7.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.6.4 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.6.5 Auris Health Key News & Latest Developments
7.7 Angiodynamics
7.7.1 Angiodynamics Company Summary
7.7.2 Angiodynamics Business Overview
7.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.7.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.7.5 Angiodynamics Key News & Latest Developments
7.8 Boston Scientific
7.8.1 Boston Scientific Company Summary
7.8.2 Boston Scientific Business Overview
7.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.8.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.8.5 Boston Scientific Key News & Latest Developments
7.9 Smith and Nephew
7.9.1 Smith and Nephew Company Summary
7.9.2 Smith and Nephew Business Overview
7.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.9.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.9.5 Smith and Nephew Key News & Latest Developments
7.10 VISON Medical
7.10.1 VISON Medical Company Summary
7.10.2 VISON Medical Business Overview
7.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.10.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.10.5 VISON Medical Key News & Latest Developments
7.11 Nanjing MICRO-TECH
7.11.1 Nanjing MICRO-TECH Company Summary
7.11.2 Nanjing MICRO-TECH Business Overview
7.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.11.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.11.5 Nanjing MICRO-TECH Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の肺がん低侵襲治療市場予測2023-2029：肺腫瘍アブレーション、肺腫瘍塞栓術 |
| 【英語タイトル】Minimally Invasive Treatment of Lung Cancer Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5303 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：68 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の肺がん低侵襲治療市場規模と予測を収録しています。・世界の肺がん低侵襲治療市場：売上、2018年-2023年、2024年-2029年 ・世界の肺がん低侵襲治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の肺がん低侵襲治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肺腫瘍アブレーション」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 肺がん低侵襲治療のグローバル主要企業は、Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECHなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、肺がん低侵襲治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の肺がん低侵襲治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の肺がん低侵襲治療市場：タイプ別市場シェア、2022年 ・肺腫瘍アブレーション、肺腫瘍塞栓術 世界の肺がん低侵襲治療市場：用途別、2018年-2023年、2024年-2029年 世界の肺がん低侵襲治療市場：用途別市場シェア、2022年 ・病院、外来手術センター 世界の肺がん低侵襲治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の肺がん低侵襲治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における肺がん低侵襲治療のグローバル売上、2018年-2023年 ・主要企業における肺がん低侵襲治療のグローバル売上シェア、2022年 ・主要企業における肺がん低侵襲治療のグローバル販売量、2018年-2023年 ・主要企業における肺がん低侵襲治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECH ************************************************************* ・調査・分析レポートの概要 肺がん低侵襲治療市場の定義 市場セグメント 世界の肺がん低侵襲治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の肺がん低侵襲治療市場規模 世界の肺がん低侵襲治療市場規模：2022年 VS 2029年 世界の肺がん低侵襲治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの肺がん低侵襲治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の肺がん低侵襲治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：肺腫瘍アブレーション、肺腫瘍塞栓術 肺がん低侵襲治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、外来手術センター 肺がん低侵襲治療の用途別グローバル売上・予測 ・地域別市場分析 地域別肺がん低侵襲治療市場規模 2022年と2029年 地域別肺がん低侵襲治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic、 Olympus、 LungCare、 Broncus、 Intuitive Surgica、 Auris Health、 Angiodynamics、 Boston Scientific、 Smith and Nephew、 VISON Medical、 Nanjing MICRO-TECH ... |
The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
This report aims to provide a comprehensive presentation of the global market for Minimally Invasive Treatment of Lung Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Minimally Invasive Treatment of Lung Cancer. This report contains market size and forecasts of Minimally Invasive Treatment of Lung Cancer in global, including the following market information:
Global Minimally Invasive Treatment of Lung Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Minimally Invasive Treatment of Lung Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Lung Tumor Ablation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific and Smith and Nephew, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Minimally Invasive Treatment of Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Minimally Invasive Treatment of Lung Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Type, 2022 (%)
Lung Tumor Ablation
Lung Tumor Embolization
Global Minimally Invasive Treatment of Lung Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Global Minimally Invasive Treatment of Lung Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Minimally Invasive Treatment of Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Minimally Invasive Treatment of Lung Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
Outline of Major Chapters:
Chapter 1: Introduces the definition of Minimally Invasive Treatment of Lung Cancer, market overview.
Chapter 2: Global Minimally Invasive Treatment of Lung Cancer market size in revenue.
Chapter 3: Detailed analysis of Minimally Invasive Treatment of Lung Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Minimally Invasive Treatment of Lung Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の肺がん低侵襲治療市場予測2023-2029：肺腫瘍アブレーション、肺腫瘍塞栓術] (コード：MMG23JU5303)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の肺がん低侵襲治療市場予測2023-2029：肺腫瘍アブレーション、肺腫瘍塞栓術]についてメールでお問い合わせ |
